peginterferon alfa-2a

Pronunciation: (peg-IN-ter-FEER-on AL-fuh ...)

A drug used to treat hepatitis C infections. It is also being studied in the treatment and prevention of cancer. It is a cytokine that is modified in the laboratory. It is a type of biological response modifier. Also called Pegasys.

Source: NCI Dictionary of Cancer Terms

2003-11-20 Date last modified: 2007-04-12